English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 後発医薬品 > 米国ジェネリック医薬品市場の今後の見通し
カテゴリ
医薬品 (4962)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

米国ジェネリック医薬品市場の今後の見通し

U.S. Generic Pharmaceuticals Outlook

発行 Frost & Sullivan
出版日 2007年04月 商品コード 51697
ページ情報 英文 66 Pages
価格
US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License)
US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This Frost & Sullivan research service titled U.S. Generic Pharmaceuticals Market Outlook provides a detailed analysis of this market, including competitive structure, market and revenue forecasts, and market share analysis. It also examines the major industry challenges and identifies the most promising opportunities for future market growth.

This research service is available through our Pharmaceuticals and Biotechnology Growth Partnership Service program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

1 EXECUTIVE SUMMARY

  • Executive Summary
    • Executive Summary

2 U.S. GENERIC PHARMACEUTICALS MARKET

  • Market Overview
    • Introduction
    • Scope and Segmentation
    • Research Methodology
  • Market Dynamics
    • Market Engineering Measurements
    • Market Trends
    • Financial Snapshot
  • Market Forecasts
    • Prescription Forecasts
    • Revenue Forecasts
  • Competitive Landscape
    • Competitive Structure
    • Pipeline Analysis
    • Market Share Analysis
  • Challenges and Opportunities
    • Industry Challenges
    • Opportunities

3 DECISION SUPPORT DATABASES

  • Demographic Indicator
    • Total Population
  • Market Indicators
    • Government Healthcare Expenditure
    • Private Healthcare Expenditure
    • Pharmaceutical R&D Expenditure
    • Percent Pharmaceutical R&D Expenditure
    • Number of Hospitals
Back to Top